|
FAM82A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.742400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.428800E-01 |
| Normal-vs-Stage2 |
9.223800E-01 |
| Normal-vs-Stage3 |
2.866200E-01 |
| Normal-vs-Stage4 |
9.985600E-01 |
| Stage1-vs-Stage2 |
4.097800E-01 |
| Stage1-vs-Stage3 |
1.939950E-02 |
| Stage1-vs-Stage4 |
4.487400E-01 |
| Stage2-vs-Stage3 |
4.263600E-01 |
| Stage2-vs-Stage4 |
9.264200E-01 |
| Stage3-vs-Stage4 |
3.123400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.896200E-01 |
| Normal-vs-AfricanAmerican |
4.439500E-02 |
| Normal-vs-Asian |
3.986000E-01 |
| Caucasian-vs-AfricanAmerican |
3.963900E-02 |
| Caucasian-vs-Asian |
2.961400E-01 |
| AfricanAmerican-vs-Asian |
2.631600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.839800E-01 |
| Normal-vs-Female |
5.357000E-01 |
| Male-vs-Female |
1.475610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.065600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.857400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.018200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.291240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.922400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.045170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.288020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.760400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.751210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.048000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.011600E-01 |
| Classical-VS-Follicular |
3.031000E-01 |
| Classical-VS-Other |
3.634800E-01 |
| Classical-VS-Normal |
4.982400E-01 |
| Tall-VS-Follicular |
9.844400E-01 |
| Tall-VS-Other |
6.546000E-01 |
| Tall-VS-Normal |
7.678400E-01 |
| Follicular-VS-Other |
7.070200E-01 |
| Follicular-VS-Normal |
7.674800E-01 |
| Other-VS-Normal |
6.391200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.486000E-01 |
| Normal-vs-N1 |
7.496000E-02 |
| N0-vs-N1 |
3.732000E-02 |
|
|
